Genmab As Stock Technical Analysis

GNMSF Stock  USD 212.50  4.81  2.32%   
As of the 2nd of December, Genmab AS retains the Market Risk Adjusted Performance of (1.29), risk adjusted performance of (0.08), and Standard Deviation of 2.89. Genmab AS technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Genmab AS variance and value at risk to decide if Genmab AS is priced fairly, providing market reflects its last-minute price of 212.5 per share. Given that Genmab AS has information ratio of (0.16), we strongly advise you to confirm Genmab AS's regular market performance to make sure the company can sustain itself at a future point.

Genmab AS Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Genmab, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Genmab
  
Genmab AS's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Genmab AS technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
A focus of Genmab AS technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Genmab AS trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Genmab AS Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Genmab AS volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Genmab AS Trend Analysis

Use this graph to draw trend lines for Genmab AS. You can use it to identify possible trend reversals for Genmab AS as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Genmab AS price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Genmab AS Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Genmab AS applied against its price change over selected period. The best fit line has a slop of   0.99  , which may suggest that Genmab AS market price will keep on failing further. It has 122 observation points and a regression sum of squares at 36805.38, which is the sum of squared deviations for the predicted Genmab AS price change compared to its average price change.

About Genmab AS Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Genmab AS on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Genmab AS based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Genmab AS price pattern first instead of the macroeconomic environment surrounding Genmab AS. By analyzing Genmab AS's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Genmab AS's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Genmab AS specific price patterns or momentum indicators. Please read more on our technical analysis page.

Genmab AS December 2, 2024 Technical Indicators

Most technical analysis of Genmab help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Genmab from various momentum indicators to cycle indicators. When you analyze Genmab charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Complementary Tools for Genmab Pink Sheet analysis

When running Genmab AS's price analysis, check to measure Genmab AS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genmab AS is operating at the current time. Most of Genmab AS's value examination focuses on studying past and present price action to predict the probability of Genmab AS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genmab AS's price. Additionally, you may evaluate how the addition of Genmab AS to your portfolios can decrease your overall portfolio volatility.
CEOs Directory
Screen CEOs from public companies around the world
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Bonds Directory
Find actively traded corporate debentures issued by US companies
Transaction History
View history of all your transactions and understand their impact on performance
Money Managers
Screen money managers from public funds and ETFs managed around the world
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.